Annual CFF
$677.55 M
+$314.83 M+86.80%
December 31, 2024
Summary
- As of March 12, 2025, IDYA annual cash flow from financing activities is $677.55 million, with the most recent change of +$314.83 million (+86.80%) on December 31, 2024.
- During the last 3 years, IDYA annual CFF has risen by +$532.10 million (+365.82%).
- IDYA annual CFF is now at all-time high.
Performance
IDYA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.75 M
-$283.75 M-99.04%
December 31, 2024
Summary
- As of March 12, 2025, IDYA quarterly cash flow from financing activities is $2.75 million, with the most recent change of -$283.75 million (-99.04%) on December 31, 2024.
- Over the past year, IDYA quarterly CFF has dropped by -$346.36 million (-99.21%).
- IDYA quarterly CFF is now -99.21% below its all-time high of $349.11 million, reached on March 31, 2024.
Performance
IDYA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$677.55 M
-$138.14 M-16.94%
December 31, 2024
Summary
- As of March 12, 2025, IDYA TTM cash flow from financing activities is $677.55 million, with the most recent change of -$138.14 million (-16.94%) on December 31, 2024.
- Over the past year, IDYA TTM CFF has dropped by -$31.35 million (-4.42%).
- IDYA TTM CFF is now -16.94% below its all-time high of $815.69 million, reached on September 30, 2024.
Performance
IDYA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
IDYA Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +86.8% | -99.2% | -4.4% |
| 3 y3 years | +365.8% | -99.2% | -4.4% |
| 5 y5 years | +1238.8% | -99.2% | -4.4% |
IDYA Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +597.3% | -99.2% | +749.7% | -16.9% | +664.7% |
| 5 y | 5-year | at high | +1238.8% | -99.2% | +7997.1% | -16.9% | +1238.8% |
| alltime | all time | at high | +3773.9% | -99.2% | +433.3% | -16.9% | >+9999.0% |
IDEAYA Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $677.55 M(+86.8%) | $2.75 M(-99.0%) | $677.55 M(-16.9%) |
| Sep 2024 | - | $286.50 M(+631.2%) | $815.69 M(+46.4%) |
| Jun 2024 | - | $39.18 M(-88.8%) | $557.02 M(-21.4%) |
| Mar 2024 | - | $349.11 M(+147.8%) | $708.90 M(+95.4%) |
| Dec 2023 | $362.72 M(+273.3%) | $140.89 M(+406.2%) | $362.72 M(+63.3%) |
| Sep 2023 | - | $27.83 M(-85.4%) | $222.15 M(-23.4%) |
| Jun 2023 | - | $191.06 M(+6429.8%) | $290.01 M(+191.6%) |
| Mar 2023 | - | $2.93 M(+803.1%) | $99.44 M(+2.3%) |
| Dec 2022 | $97.17 M(-33.2%) | $324.00 K(-99.7%) | $97.17 M(-0.4%) |
| Sep 2022 | - | $95.70 M(>+9900.0%) | $97.53 M(+10.1%) |
| Jun 2022 | - | $491.00 K(-24.8%) | $88.61 M(-14.9%) |
| Mar 2022 | - | $653.00 K(-5.1%) | $104.10 M(-28.4%) |
| Dec 2021 | $145.45 M | $688.00 K(-99.2%) | $145.45 M(-4.1%) |
| Sep 2021 | - | $86.78 M(+442.8%) | $151.72 M(+64.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $15.99 M(-61.9%) | $92.01 M(-46.1%) |
| Mar 2021 | - | $42.00 M(+504.5%) | $170.72 M(+32.6%) |
| Dec 2020 | $128.75 M(+154.4%) | $6.95 M(-74.3%) | $128.75 M(+5.7%) |
| Sep 2020 | - | $27.07 M(-71.4%) | $121.84 M(+28.9%) |
| Jun 2020 | - | $94.70 M(>+9900.0%) | $94.50 M(+83.6%) |
| Mar 2020 | - | $34.00 K(-10.5%) | $51.47 M(+1.7%) |
| Dec 2019 | $50.61 M(-52.0%) | $38.00 K(-113.8%) | $50.61 M(+0.2%) |
| Sep 2019 | - | -$276.00 K(-100.5%) | $50.49 M(-0.6%) |
| Jun 2019 | - | $51.67 M(-6355.9%) | $50.81 M(-5953.9%) |
| Mar 2019 | - | -$826.00 K(+972.7%) | -$868.00 K(-100.8%) |
| Dec 2018 | $105.38 M(+502.5%) | -$77.00 K(-287.8%) | $105.38 M(-0.1%) |
| Sep 2018 | - | $41.00 K(-783.3%) | $105.45 M(+0.0%) |
| Jun 2018 | - | -$6000.00(-100.0%) | $105.41 M(-0.0%) |
| Mar 2018 | - | $105.42 M | $105.42 M |
| Dec 2017 | $17.49 M | - | - |
FAQ
- What is IDEAYA Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual CFF year-on-year change?
- What is IDEAYA Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly CFF year-on-year change?
- What is IDEAYA Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for IDEAYA Biosciences?
- What is IDEAYA Biosciences TTM CFF year-on-year change?
What is IDEAYA Biosciences annual cash flow from financing activities?
The current annual CFF of IDYA is $677.55 M
What is the all time high annual CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual cash flow from financing activities is $677.55 M
What is IDEAYA Biosciences annual CFF year-on-year change?
Over the past year, IDYA annual cash flow from financing activities has changed by +$314.83 M (+86.80%)
What is IDEAYA Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of IDYA is $2.75 M
What is the all time high quarterly CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly cash flow from financing activities is $349.11 M
What is IDEAYA Biosciences quarterly CFF year-on-year change?
Over the past year, IDYA quarterly cash flow from financing activities has changed by -$346.36 M (-99.21%)
What is IDEAYA Biosciences TTM cash flow from financing activities?
The current TTM CFF of IDYA is $677.55 M
What is the all time high TTM CFF for IDEAYA Biosciences?
IDEAYA Biosciences all-time high TTM cash flow from financing activities is $815.69 M
What is IDEAYA Biosciences TTM CFF year-on-year change?
Over the past year, IDYA TTM cash flow from financing activities has changed by -$31.35 M (-4.42%)